The top 15 highest-Paid Biopharma Executives
Tracking executive pay follows a familiar pattern: Collect compensation disclosures, read said documents as they pile up, and when the usual suspects have all filed their annual reports and proxy statements, put the numbers into a spreadsheet and sort descending. The first documents surface as early as January and trickle into May. European Big Pharma comes first; a certain few U.S. drugmakers file their proxies much later than the rest...
Login to comment.